Unclaimed brand
Eleva Biologics is a strategic partner for the discovery and development of highly complex biologics. Our proprietary moss-based Bryotechnology platform unlocks therapeutic proteins that are otherwise difficult or impossible to manufacture, including recombinant antibody modalities, multi-domain fusions, and other complex proteins. It offers precise control over glycosylation, ensures homogeneous production of complex proteins with correct folding and assembly, and integrates seamlessly into standard infrastructure. Our platform has produced two moss-derived candidates that have advanced into clinical development: a first-in-class, full-length recombinant human Factor H and a highly differentiated α-galactosidase.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#33338E
Minsk
51, 51, 142
240, 47, 38
64, 64, 0, 44
#DADADA
Alto
218, 218, 218
0, 0, 85
0, 0, 0, 15
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
Eleva Biologics is a biotechnology company focused on discovering and developing biologic medicines that are difficult or impossible to produce using conventional platforms. Its work aims to turn complex, previously inaccessible biologics into potential treatments for diseases where innovation could benefit patients with limited or no treatment options. The company develops a pipeline of differentiated product candidates and supports innovative therapies in early development.
Eleva’s technology enables the production of complex biologics, including recombinant antibody modalities and structurally complex blood proteins. Through discovery, development and co-development, the company positions itself as a strategic partner for advancing these challenging medicines. Its team brings expertise across technology, lead discovery, CMC and quality, and business development.
Eleva Biologics also shares company and scientific updates through its news and events program, and invites organizations to explore partnering opportunities. The company is based in Freiburg, Germany, and offers careers for people interested in helping bring novel or improved therapies to patients.
Company type
Public Company
Year founded
1999
Company size
11-50 employees
